Retailer will begin by closing 40 underperforming stores, netting $4M in savings.
George Barrett sees a more active consumer, which could lead to more patient-centered policies.
London Drugs is hoping to beat Shoppers Drug Mart to market in terms of dispensing medical marijuana, Canada's Tri-City News reported Thursday. “We’ll be as fast as the laws allow," London Drugs VP John Tse told the Candadian daily, "but it could happen overnight, we’re that ready." London Drug pharmacists are already reviewing potential drug-drug interactions. "We're interested from the perspective of how does it affect other medication the patient might be on and other health conditions they might have,” Tse said. “As a pharmacy we want it all documented properly so that we can advise patients and other health care professionals.” (Tri-City News)
The company told USA Today the cuts would take effect Feb. 10, with its Fairfax, Delaware headquarters seeing about 120 of the expected cuts, with other impacted roles spanning those that are field-based in both sales and non-sales.
A new report from Evaluate’s editorial branch EP Vantage, 2017 could be a year of increased corporate activity and cash flow in the biopharmaceutical industry, partially as a result of the incoming Trump administration.
In addition to returning the rights to Belbuca to BioDelivery Sciences International, Endo will be eliminating its 375-member pain sales field force in an effort to refocus its U.S. branded strategy on specialty, including its Xiaflex.
higi’s health screening stations and omni-channel consumer engagement platform provide benefits for consumers, pharmacy retailers and health care stakeholders.
President Obama said in his Dec. 3 weekly address that he would sign the legislation into law "as soon as it reaches my desk."
The brand unites American Homecare Federation, At-Home IV Infusion Professional, BioRx, MedPro Rx and XAS infusion services under Diplomat Specialty Infusion Group.